Iright
BRAND / VENDOR: Biolegend

Biolegend, 405206, PE/Cyanine7 Streptavidin, 100μg

CATALOG NUMBER: 405206
السعر العادي$0.99
/
  • In stock, ready to ship

  • الطلب مؤجل، سيتم الشحن قريباً

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

Product Description

Streptavidin binds to biotin with high affinity. Streptavidin - Phycoerythrin/Cyanine7 (PE/Cyanine7) is useful for detecting biotinylated antibodies. The excitation of PE/Cyanine7 by 488 nm laser light induces a light emission maximum of 775 nm.
100μg
Verified Reactivity: Human, Mouse, Rat, All Species
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: Streptavidin is conjugated with PE/Cyanine7 under optimal conditions.
Concentration: 0.2 mg/ml (concentration relates to the Streptavidin only component of the conjugate)
Storage & Handling: The Streptavidin-PE/Cyanine7 solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested ICFC - Verified
Recommended Usage: Each lot of this Streptavidin-PE/Cyanine7 is quality control tested by immunofluorescent staining with flow cytometric analysis. The concentration provided is based upon molecular molar mass of streptavidin independent of any additional molecular mass that might be added by the PE/Cyanine7 conjugation. For immunofluorescent staining, the recommended use of this reagent is =0.125 µg per 106 cells in 100 µl staining volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: Streptavidin - Phycoerythrin/Cyanine7 (PE/Cyanine7) is useful as a second step reagent for indirect immunofluorescent staining, when used in conjunction with biotinylated primary antibodies. The average molecular weight of Streptavidin-PE/Cyanine7 is 360 kD and Streptavidin alone is 52 kD.
Application References(PubMed link indicates BioLegend citation): Kamimura D, et al. 2006. J. Immunol. 177:306. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. Anderson SM, et al. 2007. J. Exp. Med. doi:10.1084/jem.20062571. PubMed Rigolio R, et al. 2008. J Neuroimmunol. 199:67. PubMed Chappaz S, et al. 2010. J. Immunol. 184:3562. PubMed Weber SE, et al. 2011. J. Immunol. 186:432. PubMed Chamoto, K., et al. 2011. Am J Respir Cel Mol Biol. PubMed Ahuja, A., et al. 2011. J. Immunol. 187:3888. PubMed Chamoto K, et al. 2012. Am J Respir Cell Mol Biol. 46:283. PubMed Sugiura D, et al. 2012. PLoS One. 7:e44770. PubMed Nakamura M, et al. 2014. Mult Scler. PubMed Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed Shaw OM, et al. 2014. Rheumatology. PubMed Markey KA, et al. 2014. J Immunol. 192:5426. PubMed Yasunaga M, et al. 2014. Sci Rep. 4:4852. PubMed Nakamura M, et al. 2014. Mult Scler. 20:1371. PubMed Shaw OM, et al. 2014. Rheumatology. 53:1901. PubMed Tang AH, et al. 2014. EMBO J. 33:2782. PubMed
Product Citations: Li Y, et al. 2020. Nat Commun. 2.350694444. PubMed Hu XF, et al. 2021. Theranostics. 3796:11. PubMed Tarazi S, et al. 2022. Cell. 185:3290. PubMed Takano T, et al. 2023. Nat Commun. 14:1451. PubMed Shao X, et al. 2023. Cell Discov. 9:44. PubMed Geng G, et al. 2021. Elife. 10: . PubMed Hu XX, et al. 2022. Acta Pharmacol Sin. 43:387. PubMed Goel RR, et al. 2022. Cell. 185:1875. PubMed Gargaro M, et al. 2022. Immunity. 55:1032. PubMed Hu Q, et al. 2022. Cell Rep. 40:111035. PubMed Weskamm LM, et al. 2022. Cell Rep Med. 3:100685. PubMed Pribluda A, et al. 2022. Elife. 11: . PubMed Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed Meyer S, et al. 2023. Cell Rep. 42:111995. PubMed Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed Ahuja A, et al. 2011. J Immunol. 187:3888. PubMed Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed Poon MML, et al. 2021. Sci Immunol. 6:eabl9105. PubMed Afroj T, et al. 2021. J Immunol. 206:1204. PubMed Zhou S, et al. 2020. Cell Res. 30:1063. PubMed Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed Finke S 2010. J Immunol. 184:3562. PubMed Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed Zheng H, et al. 2017. Sci Rep. 7:37. PubMed Kitano M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1044 - 1049. PubMed Anderson S, et al. 2007. J Exp Med. 204:2103. PubMed Tang D, et al. 2020. Br J Haematol. 191:906. PubMed Khateb M, et al. 2022. Cell Rep. 40:111219. PubMed Han YH, et al. 2021. Science. 373:. PubMed Kunimoto H, et al. 2012. Sci Rep. 0.272916667. PubMed Terashima Y, et al. 2020. Nat Commun. 11:609. PubMed Zou T, et al. 2010. J Immunol. 185:2790. PubMed Schenk R, et al. 2017. Cell Death Differ. 10.1038/cdd.2016.156. PubMed Chamoto K, et al. 2012. Am J Respir Cell Mol Biol. 46:283. PubMed Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed Gressler AE, et al. 2022. Front Immunol. 13:896255. PubMed Bahal R, et al. 2016. Nat Commun. 7:13304. PubMed Rowan A, et al. 2016. PLoS Pathog. 12:e1006030. PubMed Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed Watson JK, et al. 2020. Sci Rep. 10:10490. PubMed Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed Trinh T, et al. 2020. Leukemia. . PubMed Dawar S, et al. 2016. Cell Death Dis. 7:e2509. PubMed Schmid M, et al. 2016. PLoS One. 12: 1005676. PubMed Sebastian M, et al. 2016. J Immunol. 196: 144 - 155. PubMed Markey K, et al. 2014. J Immunol. 192:5426. PubMed Sugiura D, et al. 2012. PLoS One. 7:e44770. PubMed Tarke A, et al. 2022. Cell. 185:847. PubMed Matsumura M 2014. Sci Rep. 4:4852. PubMed Rando A 2014. EMBO J. 33:2782. PubMed Cassotta A, et al. 2020. J Exp Med. 217:00:00. PubMed Hermann BP, et al. 2018. Cell Rep. 25:1650. PubMed Delacher M, et al. 2020. Immunity. 52:295. PubMed Mueller A, et al. 2016. Nature. 540:276-279. PubMed Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed Shaw O, et al. 2014. Rheumatology. 53:1901. PubMed Zhi Z, et al. 2021. Cell Death Differ. Online ahead of print.. PubMed Dan JM, et al. 2021. Science. :371. PubMed Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed Nakamura M, et al. 2014. Mult Scler. 20:1371. PubMed De Micheli AJ, et al. 2020. Cell Rep. 30:3583. PubMed Zeng W, et al. 2022. Nat Commun. 13:947. PubMed Rigolio R, et al. 2008. J Neuroimmunol. 199:67. PubMed Kato Y, et al. 2015. J Immunol. 195: 1006-1014. PubMed Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed Werner A, et al. 2021. iScience. 24:103076. PubMed Ubags ND, et al. 2021. J Allergy Clin Immunol. 1049:147. PubMed Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed Halvarsson C, et al. 2019. Antioxid Redox Signal. 31:211. PubMed Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed Getahun A, et al. 2016. J Exp Med. 213: 751 - 769. PubMed Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed Gozdecka M, et al. 2018. Nat Genet. 50:883. PubMed Tichy ED, et al. 2021. STAR Protoc. 2:100830. PubMed Tichy ED, et al. 2021. Cell Rep. 35:109098. PubMed Spath S, et al. 2022. iScience. 25:104998. PubMed Weber S, et al. 2011. J Immunol. 186:432. PubMed Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
Gene ID: NA
UniProt: View information about Biotin on UniProt.org
Regulatory Status: RUO
Other Names: SAv-PE/Cyanine7


Order Guidelines

1. Price & Stock Available on Request. 📧Click to send email to: service@iright.com

2. Please DO NOT make payment before confirmation.

3. Minimum order value of $1,000 USD required.

Collaboration

Tony Tang

📧Email: Tony.Tang@iright.com

📱Mobile/WhatsApp/Wechat: +86-17717886924